Combined antiplatelet and novel oral anticoagulant therapy after acute coronary syndrome: is three a crowd?

被引：9
|
作者：
Verheugt, Freek W. A. [1 ]
机构：
[1] Onze Lieve Vrouw Hosp, Dept Cardiol, Heartctr, NL-1091 AC Amsterdam, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷 / 22期
关键词：
CLOPIDOGREL; RIVAROXABAN; PRASUGREL; WARFARIN; ASPIRIN;
D O I：
10.1093/eurheartj/eht075
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1618 / 1620
页数：3
相关论文
共 50 条
  • [1] Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review
    Kamran, Hassan
    Jneid, Hani
    Kayani, Waleed T.
    Virani, Salim S.
    Levine, Glenn N.
    Nambi, Vijay
    Khalid, Umair
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (15): : 1545 - 1555
  • [2] Oral antiplatelet therapy in the treatment of acute coronary syndrome
    Yalcin, Ridvan
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2013, 41 : 4 - 11
  • [3] Oral anticoagulant use in addition to antiplatelet therapy for secondary prevention in acute coronary syndrome: current perspectives
    Turpie, Alexander G. G.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (08) : 963 - 976
  • [4] Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
    Alexander, John H.
    Lopes, Renato D.
    James, Stefan
    Kilaru, Rakhi
    He, Yaohua
    Mohan, Puneet
    Bhatt, Deepak L.
    Goodman, Shaun
    Verheugt, Freek W.
    Flather, Marcus
    Huber, Kurt
    Liaw, Danny
    Husted, Steen E.
    Lopez-Sendon, Jose
    De Caterina, Raffaele
    Jansky, Petr
    Darius, Harald
    Vinereanu, Dragos
    Cornel, Jan H.
    Cools, Frank
    Atar, Dan
    Luis Leiva-Pons, Jose
    Keltai, Matyas
    Ogawa, Hisao
    Pais, Prem
    Parkhomenko, Alexander
    Ruzyllo, Witold
    Diaz, Rafael
    White, Harvey
    Ruda, Mikhail
    Geraldes, Margarida
    Lawrence, Jack
    Harrington, Robert A.
    Wallentin, Lars
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08): : 699 - 708
  • [5] Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome
    Jeffrey S. Berger
    American Journal of Cardiovascular Drugs, 2018, 18 : 457 - 472
  • [6] Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome
    Berger, Jeffrey S.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (06) : 457 - 472
  • [7] The role of oral anticoagulant therapy in patients with acute coronary syndrome
    Moon, Jae Youn
    Nagaraju, Deepa
    Franchi, Francesco
    Rollini, Fabiana
    Angiolillo, Dominick J.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2017, 8 (12) : 353 - 366
  • [8] Considerations in patients receiving oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention
    Roffman, David S.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (15) : S18 - S24
  • [9] Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndrome
    Olivier, Christoph B.
    Turakhia, Mintu P.
    Mahaffey, Kenneth W.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (03) : 251 - 258
  • [10] Complications of dual antiplatelet therapy combined with an oral anticoagulation in patients with Acute Coronary Syndrome treated with PCI
    Banaszewski, M.
    Drozdz, J.
    Wozakowska-Kaplon, B.
    Ablewska, U.
    Wojtkowska, I.
    Stepinska, J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 666 - 666
12345